Literature DB >> 27229375

Algorithm-driven optimization of cryopreservation protocols for transfusion model cell types including Jurkat cells and mesenchymal stem cells.

Kathryn Pollock1, Joseph W Budenske1, David H McKenna2, Peter I Dosa3, Allison Hubel4.   

Abstract

This investigation describes the use of a differential evolution (DE) algorithm to optimize cryopreservation solution compositions and cooling rates for specific cell types. Jurkat cells (a lymphocyte model cell type) and mesenchymal stem cells (MSCs) were combined with non-DMSO solutions at concentrations dictated by a DE algorithm. The cells were then frozen in 96-well plates at DE algorithm-dictated cooling rates in the range 0.5-10°C/min. The DE algorithm was iterated until convergence resulted in identification of an optimum solution composition and cooling rate, which occurred within six to nine generations (seven to 10 experiments) for both cell types. The optimal composition for cryopreserving Jurkat cells included 300 mm trehalose, 10% glycerol and 0.01% ectoine (TGE) at 10°C/min. The optimal composition for cryopreserving MSCs included 300 mm ethylene glycol, 1 mm taurine and 1% ectoine (SEGA) at 1°C/min. High-throughput concentration studies verified the optimum identified by the DE algorithm. Vial freezing experiments showed that experimental solutions of TGE at 10°C/min resulted in significantly higher viability for Jurkat cells than DMSO at 1°C/min, while experimental solutions of SEGA at 10°C/min resulted in significantly higher recovery for MSCs than DMSO at 1°C/min; these results were solution- and cell type-specific. Implementation of the DE algorithm permits optimization of multicomponent freezing solutions in a rational, accelerated fashion. This technique can be applied to optimize freezing conditions, which vary by cell type, with significantly fewer experiments than traditional methods.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  algorithm; cryopreservation; freezing; lymphocytes; mesenchymal stem cells; optimization; recovery

Mesh:

Substances:

Year:  2016        PMID: 27229375      PMCID: PMC5769925          DOI: 10.1002/term.2175

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  23 in total

1.  Cell therapy industry: billion dollar global business with unlimited potential.

Authors:  Chris Mason; David A Brindley; Emily J Culme-Seymour; Natasha L Davie
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

2.  An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells.

Authors:  Hideaki Tsutsui; Bahram Valamehr; Antreas Hindoyan; Rong Qiao; Xianting Ding; Shuling Guo; Owen N Witte; Xin Liu; Chih-Ming Ho; Hong Wu
Journal:  Nat Commun       Date:  2011-01-25       Impact factor: 14.919

3.  Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.

Authors:  P Windrum; T C M Morris; M B Drake; D Niederwieser; T Ruutu
Journal:  Bone Marrow Transplant       Date:  2005-10       Impact factor: 5.483

Review 4.  Freezing of living cells: mechanisms and implications.

Authors:  P Mazur
Journal:  Am J Physiol       Date:  1984-09

5.  Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body.

Authors:  Misa Iwatani; Kohta Ikegami; Yuliya Kremenska; Naka Hattori; Satoshi Tanaka; Shintaro Yagi; Kunio Shiota
Journal:  Stem Cells       Date:  2006-07-13       Impact factor: 6.277

6.  Effects of cryobiological variables on the survival of skin using a defined murine model.

Authors:  J N Kearney; L A Wheldon; G Gowland
Journal:  Cryobiology       Date:  1990-04       Impact factor: 2.487

7.  Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.

Authors:  Parul Trivedi; Peiman Hematti
Journal:  Exp Hematol       Date:  2008-01-07       Impact factor: 3.084

8.  Optimization of the freezing process for hematopoietic progenitor cells: effect of precooling, initial dimethyl sulfoxide concentration, freezing program, and storage in vapor-phase or liquid nitrogen on in vitro white blood cell quality.

Authors:  Margriet J Dijkstra-Tiekstra; Airies C Setroikromo; Marcha Kraan; Effimia Gkoumassi; Janny de Wildt-Eggen
Journal:  Transfusion       Date:  2014-08-11       Impact factor: 3.157

9.  Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.

Authors:  Moïra François; Ian B Copland; Shala Yuan; Raphaëlle Romieu-Mourez; Edmund K Waller; Jacques Galipeau
Journal:  Cytotherapy       Date:  2011-10-27       Impact factor: 5.414

10.  Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo.

Authors:  Raghavan Chinnadurai; Marco A Garcia; Yumiko Sakurai; Wilbur A Lam; Allan D Kirk; Jacques Galipeau; Ian B Copland
Journal:  Stem Cell Reports       Date:  2014-06-06       Impact factor: 7.765

View more
  10 in total

1.  Improved Post-Thaw Function and Epigenetic Changes in Mesenchymal Stromal Cells Cryopreserved Using Multicomponent Osmolyte Solutions.

Authors:  Kathryn Pollock; Rebekah M Samsonraj; Amel Dudakovic; Roman Thaler; Aron Stumbras; David H McKenna; Peter I Dosa; Andre J van Wijnen; Allison Hubel
Journal:  Stem Cells Dev       Date:  2017-03-15       Impact factor: 3.272

Review 2.  Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.

Authors:  Xue Yao; Sandro Matosevic
Journal:  BioDrugs       Date:  2021-08-24       Impact factor: 5.807

Review 3.  Chemical approaches to cryopreservation.

Authors:  Kathryn A Murray; Matthew I Gibson
Journal:  Nat Rev Chem       Date:  2022-07-18       Impact factor: 34.571

4.  Combinations of Osmolytes, Including Monosaccharides, Disaccharides, and Sugar Alcohols Act in Concert During Cryopreservation to Improve Mesenchymal Stromal Cell Survival.

Authors:  Kathryn Pollock; Guanglin Yu; Ralph Moller-Trane; Marissa Koran; Peter I Dosa; David H McKenna; Allison Hubel
Journal:  Tissue Eng Part C Methods       Date:  2016-10-27       Impact factor: 3.056

5.  Understanding the freezing responses of T cells and other subsets of human peripheral blood mononuclear cells using DSMO-free cryoprotectants.

Authors:  Chia-Hsing Pi; Kathlyn Hornberger; Peter Dosa; Allison Hubel
Journal:  Cytotherapy       Date:  2020-03-25       Impact factor: 5.414

6.  Natural deep eutectic systems for nature-inspired cryopreservation of cells.

Authors:  Kathlyn Hornberger; Rui Li; Ana Rita C Duarte; Allison Hubel
Journal:  AIChE J       Date:  2020-10-02       Impact factor: 4.167

7.  On-demand serum-free media formulations for human hematopoietic cell expansion using a high dimensional search algorithm.

Authors:  Michelle M Kim; Julie Audet
Journal:  Commun Biol       Date:  2019-02-01

8.  Cryopreservation of Human iPS Cell Aggregates in a DMSO-Free Solution-An Optimization and Comparative Study.

Authors:  Rui Li; Kathlyn Hornberger; James R Dutton; Allison Hubel
Journal:  Front Bioeng Biotechnol       Date:  2020-01-22

9.  Characterizing the "sweet spot" for the preservation of a T-cell line using osmolytes.

Authors:  Chia-Hsing Pi; Guanglin Yu; Ashley Petersen; Allison Hubel
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

10.  Quantitative analysis of F-actin alterations in adherent human mesenchymal stem cells: Influence of slow-freezing and vitrification-based cryopreservation.

Authors:  Yannik Müllers; Ina Meiser; Frank Stracke; Iris Riemann; Franziska Lautenschläger; Julia C Neubauer; Heiko Zimmermann
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.